Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Medtronic
MDT
|
$580M |
| 2 |
Citigroup
C
|
$486M |
| 3 |
Cimpress
CMPR
|
$398M |
| 4 |
Broadcom
AVGO
|
$367M |
| 5 |
Apple
AAPL
|
$285M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
$348M |
| 2 |
Microsoft
MSFT
|
$337M |
| 3 |
IQVIA
IQV
|
$249M |
| 4 |
Costco
COST
|
$202M |
| 5 |
AbbVie
ABBV
|
$177M |
Sector Composition
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.75% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIB
901
Trinity Biotech
TRIB
$4.32M
| $7.93M | 0.01% |
282,858
| – | – |
|
902
Qorvo
QRVO
$8.61B
| $7.9M | 0.01% |
111,777
+33,895
| +44% | +$2.4M |
|
903
Camden Property Trust
CPT
$11.9B
| $7.89M | 0.01% |
86,324
+40,234
| +87% | +$3.68M |
|
904
Vanguard FTSE Pacific ETF
VPL
$7.79B
| $7.82M | 0.01% |
114,728
+61,916
| +117% | +$4.22M |
|
905
The Mosaic Company
MOS
$10.3B
| $7.82M | 0.01% |
362,064
+50,776
| +16% | +$1.1M |
|
906
Embraer
ERJ
$11.2B
| $7.76M | 0.01% |
343,430
| – | – |
|
|
CRCM
907
DELISTED
CARE.COM, INC.
CRCM
| $7.75M | 0.01% |
487,690
-426
| -0.1% | -$6.77K |
|
908
PACCAR
PCAR
$52B
| $7.67M | ﹤0.01% |
159,107
-134,914
| -46% | -$6.51M |
|
|
CIM
909
Chimera Investment
CIM
$1.2B
| $7.62M | ﹤0.01% |
134,317
-166
| -0.1% | -$9.42K |
|
|
HES
910
DELISTED
Hess
HES
| $7.58M | ﹤0.01% |
161,698
-61,579
| -28% | -$2.89M |
|
911
TransDigm Group
TDG
$71.6B
| $7.57M | ﹤0.01% |
29,615
-58,287
| -66% | -$14.9M |
|
912
Zai Lab
ZLAB
$3.42B
| $7.52M | ﹤0.01% |
+278,345
| New | +$7.52M |
|
913
Mohawk Industries
MHK
$8.65B
| $7.39M | ﹤0.01% |
29,849
-4,543
| -13% | -$1.12M |
|
914
Vanguard FTSE Europe ETF
VGK
$26.9B
| $7.36M | ﹤0.01% |
126,206
+67,213
| +114% | +$3.92M |
|
915
LeMaitre Vascular
LMAT
$2.21B
| $7.29M | ﹤0.01% |
194,891
+45,586
| +31% | +$1.71M |
|
916
Cardinal Health
CAH
$35.7B
| $7.29M | ﹤0.01% |
108,930
+47,669
| +78% | +$3.19M |
|
917
Autodesk
ADSK
$69.5B
| $7.25M | ﹤0.01% |
64,551
-3,654
| -5% | -$410K |
|
918
Generac Holdings
GNRC
$10.6B
| $7.19M | ﹤0.01% |
156,468
-417,400
| -73% | -$19.2M |
|
919
Ameriprise Financial
AMP
$46.1B
| $7.19M | ﹤0.01% |
48,378
+10,479
| +28% | +$1.56M |
|
|
MSCC
920
DELISTED
Microsemi Corp
MSCC
| $7.06M | ﹤0.01% |
+137,221
| New | +$7.06M |
|
921
Assured Guaranty
AGO
$3.91B
| $6.97M | ﹤0.01% |
184,630
-45,900
| -20% | -$1.73M |
|
|
RDFN
922
DELISTED
Redfin
RDFN
| $6.96M | ﹤0.01% |
+277,353
| New | +$6.96M |
|
923
Spirit AeroSystems
SPR
$4.8B
| $6.95M | ﹤0.01% |
89,365
-99,900
| -53% | -$7.76M |
|
|
CBIO
924
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $6.82M | ﹤0.01% |
4,875
-141
| -3% | -$197K |
|
925
Nu Skin
NUS
$569M
| $6.79M | ﹤0.01% |
110,400
+79,000
| +252% | +$4.86M |
|